The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Expression of insulin-like growth factor-1 receptor (IGF-1R) as a marker of response to erlotinib in pancreatic ductal adenocarcinoma (PDA).
A. Witkiewicz
No relevant relationships to disclose
M. E. Valsecchi
No relevant relationships to disclose
J. R. Brody
No relevant relationships to disclose
L. R. Simon
No relevant relationships to disclose
C. Yeo
No relevant relationships to disclose
B. I. Carr
No relevant relationships to disclose
C. Solomides
No relevant relationships to disclose
S. Peiper
No relevant relationships to disclose